FI117666B - Fusidihappotablettien valmistus - Google Patents

Fusidihappotablettien valmistus Download PDF

Info

Publication number
FI117666B
FI117666B FI965214A FI965214A FI117666B FI 117666 B FI117666 B FI 117666B FI 965214 A FI965214 A FI 965214A FI 965214 A FI965214 A FI 965214A FI 117666 B FI117666 B FI 117666B
Authority
FI
Finland
Prior art keywords
tablets
fusidic acid
granules
sodium salt
bulk density
Prior art date
Application number
FI965214A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI965214A (fi
FI965214A0 (fi
Inventor
Erik Preben Rasmussen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of FI965214A publication Critical patent/FI965214A/fi
Publication of FI965214A0 publication Critical patent/FI965214A0/fi
Application granted granted Critical
Publication of FI117666B publication Critical patent/FI117666B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI965214A 1994-07-26 1996-12-27 Fusidihappotablettien valmistus FI117666B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9415048A GB9415048D0 (en) 1994-07-26 1994-07-26 Tablet
GB9415048 1994-07-26
EP9502904 1995-07-21
PCT/EP1995/002904 WO1996003128A1 (en) 1994-07-26 1995-07-21 Preparation of fusidic acid tablets

Publications (3)

Publication Number Publication Date
FI965214A FI965214A (fi) 1996-12-27
FI965214A0 FI965214A0 (fi) 1996-12-27
FI117666B true FI117666B (fi) 2007-01-15

Family

ID=10758888

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965214A FI117666B (fi) 1994-07-26 1996-12-27 Fusidihappotablettien valmistus

Country Status (20)

Country Link
EP (1) EP0773783B1 (ko)
JP (1) JP3853358B2 (ko)
KR (1) KR100358614B1 (ko)
CN (1) CN1070703C (ko)
AT (1) ATE209496T1 (ko)
AU (1) AU681980B2 (ko)
CA (1) CA2193235C (ko)
CZ (1) CZ286197B6 (ko)
DE (1) DE69524226T2 (ko)
DK (1) DK0773783T3 (ko)
ES (1) ES2163521T3 (ko)
FI (1) FI117666B (ko)
GB (1) GB9415048D0 (ko)
HU (1) HU221483B (ko)
NZ (1) NZ290806A (ko)
PL (1) PL180935B1 (ko)
PT (1) PT773783E (ko)
RO (1) RO118633B1 (ko)
RU (1) RU2140272C1 (ko)
WO (1) WO1996003128A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9022098A (en) * 1997-08-20 1999-03-08 Fuisz Technologies Ltd. Process for improving flow and compression of tableting compositions
AU2006310873B2 (en) 2005-10-31 2012-05-24 Leo Pharma A/S Preparation of an antibiotic crystalline fusidic acid
FR2895908B1 (fr) * 2006-01-12 2008-03-28 France Etat Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir
JP5249568B2 (ja) * 2007-12-06 2013-07-31 旭化成ケミカルズ株式会社 成形用粉末、およびこれを用いた圧縮成形組成物、ならびに成形用粉末の製造方法
DE102008051783A1 (de) * 2008-10-17 2010-04-22 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Valsartan enthaltende Tablette
EP2382968A1 (en) 2010-03-26 2011-11-02 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Particle size distribution of fusidic acid granules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7411402A (nl) * 1973-09-13 1975-03-17 Leo Pharm Prod Ltd Werkwijze voor het bereiden van een middel tegen arthritis.
EP0300073A1 (en) * 1987-07-22 1989-01-25 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Use of fusidic acid in the treatment of aids-related complex and full-blown aids

Also Published As

Publication number Publication date
CN1154066A (zh) 1997-07-09
NZ290806A (en) 1998-01-26
AU681980B2 (en) 1997-09-11
PL318261A1 (en) 1997-05-26
PL180935B1 (pl) 2001-05-31
HU221483B (en) 2002-10-28
CA2193235A1 (en) 1996-02-08
CN1070703C (zh) 2001-09-12
CZ22997A3 (en) 1997-04-16
KR100358614B1 (ko) 2003-01-10
HUT76836A (en) 1997-11-28
AU3164495A (en) 1996-02-22
RO118633B1 (ro) 2003-08-29
GB9415048D0 (en) 1994-09-14
FI965214A (fi) 1996-12-27
EP0773783B1 (en) 2001-11-28
HU9700217D0 (en) 1997-04-28
DE69524226T2 (de) 2002-06-27
FI965214A0 (fi) 1996-12-27
CZ286197B6 (cs) 2000-02-16
KR970704447A (ko) 1997-09-06
JPH10502937A (ja) 1998-03-17
ATE209496T1 (de) 2001-12-15
DK0773783T3 (da) 2002-04-02
ES2163521T3 (es) 2002-02-01
WO1996003128A1 (en) 1996-02-08
EP0773783A1 (en) 1997-05-21
RU2140272C1 (ru) 1999-10-27
JP3853358B2 (ja) 2006-12-06
CA2193235C (en) 2008-03-18
PT773783E (pt) 2002-04-29
DE69524226D1 (de) 2002-01-10

Similar Documents

Publication Publication Date Title
RU2204996C2 (ru) Таблетка, быстро распадающаяся в щечном кармане, и способ ее изготовления
SU1577684A3 (ru) Способ получени таблеток
CN107875136B (zh) 一种阿莫西林药物制剂及其制备方法
FI101040B (fi) Menetelmä sentraalisten dopamiininpuutostilojen hoitoon tarkoitetun, p eroraalisesti annettavan lääkemuodon valmistamiseksi
US8834923B2 (en) Slow-release composition, method for the preparation thereof, and use thereof
US6291462B1 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
CN113939289A (zh) 一种含有布鲁顿氏酪氨酸激酶抑制剂的口服固体片剂及其制备方法
KR20000005486A (ko) D-만니톨 및 그의 제법
FI117666B (fi) Fusidihappotablettien valmistus
FI89238C (fi) Foerfarande foer framstaellning av kompressionsbelagda tabletter
UA27954C2 (uk) Біологічно активна речовина фармацевтичної композиції для лікування гіперглікемій та фармацевтична композиція з протигіперглікемічною активністю
CA1268706A (en) Method for simultaneously drying and granulating extract substances from deproteinized calves blood
MX2011000709A (es) Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en preparar formas de dosificacion solidas no efervescentes.
CN104146977A (zh) 一种泮托拉唑钠肠溶片及其制备方法
CN112057427A (zh) 一种含有布鲁顿氏酪氨酸激酶抑制剂的口服固体片剂及其制备方法
RU2145230C1 (ru) Таблетки "леонирид" для лечения функциональных расстройств центральной и вегетативной нервной системы
JP2000007585A (ja) 耐湿性固形製剤及びその製造方法
RU2183121C1 (ru) Фармацевтическая композиция, обладающая снотворной, седативной и транквилизирующей активностью, способ ее получения
RU2224521C2 (ru) Твердая лекарственная форма, обладающая транквилизирующим действием, и способ ее изготовления
RU2188017C1 (ru) Способ получения таблеток комбинированного препарата триметоприма с сульфаметоксазолом
CA2026384C (en) A solid drug form with a high verapamil content
JPH02167229A (ja) かわらたけ由来の蛋白多糖体の粒状製剤
RU2203056C1 (ru) Способ получения твердой лекарственной формы препарата на основе дибазола
CN104107202A (zh) 苦茶槭提取物的胶囊制备方法
RU2228751C1 (ru) Антипротозойная фармацевтическая композиция

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117666

Country of ref document: FI

MA Patent expired